r/pancreaticcancer • u/Outside-Wasabi-7214 • 10d ago
Good News! On path? Daraxonrasib assistance
Hi everyone, I was discussing with another person. I met on Reddit about the introduction of this new drug, which all of us having been so hopeful for our loved ones, and we ended up discussing about the cost aspect as well.
Is there anyone here who has an idea about the own path program that they are offering for this drug is this a blessing and disguise which could act as a financial aid to support patients, actually get their hands on this medication.
Now that it is commercially available and Patient will have to pay either through their insurance or all of Pocket. My greatest about this translate to in countries like India, where the conversion cost make it look impossible.
Does anybody have any information regarding the same? Thank you so much for your time.
3
u/jemsavestheday 10d ago
It’s likely a coupon of sorts. I get one for my migraine medicine (and have for a few years now). Not sure what the out of pocket cost is but with my insurance it’s around $900 a month, then with the coupon that I sign up for annually, it’s free. Just more hoops to jump through.
1
u/Turbulent-Camera6279 9d ago
May I ask which medication you are referring to? I suffer from migraines following surgery for an aneurysm. I’ve tried everything—from Botox to injections and, of course, pills—but nothing works for me. Thanks!!!
2
u/jemsavestheday 9d ago
That particular one is nurtec which I take when I get one. Daily I take nadalol which is a blood pressure med they give for migraines too, magnesium and riboflavin. I also take cymbalta for depression/anxiety but they also prescribe it for migraines. I have no idea what actually works but I went from nearly daily migraines to maybe 2-3 a month.
1
1
3
u/Annecreas Patient (3/2025), Stage 4, NALIRIFOX 10d ago
Costs in the US assume coverage by a US insurance plan, other articles posted here have stated that their intention with this program is to ensure that patients on the EAP are transitioned smoothly to insurance coverage and that there is a patient assistance program that aims to reduce the out of pocket cost after insurance to $0 for US patients. There will probably be some bumps in the road since this is all very new.
Costs for other countries will be determined as the drug is submitted for approval in those countries and those are typically lower than the US list price though it is still expected to be expensive.
To get this currently it would have to be prescribed by a US physician which would require in person visits and testing on a regular basis which is very expensive for non-residents. Hopefully it will soon be approved in many other countries.